Skip to main navigation Skip to search Skip to main content

Data on Crohn's Disease Reported by a Researcher at Sungkyunkwan University School of Medicine (Free antibodies-to-infliximab are biomarker for predicting the effect of dose intensification in pediatric Crohn's disease patients with secondary ...)

Press/Media

Period2023.05.22

Media coverage

1

Media coverage